Accessibility Menu
International Biotechnology Trust Plc logo

International Biotechnology Trust Plc

(LSE) IBT

Current Price£9.46
Market Cap£298.54M
Since IPO (1994)+1,375%
5 Year+32%
1 Year+59%
1 Month-2%

International Biotechnology Trust Plc Financials at a Glance

Market Cap

£298.54M

Revenue (TTM)

£117.04M

Net Income (TTM)

£94.81M

EPS (TTM)

£2.40

P/E Ratio

3.91

Dividend

£0.32

Beta (Volatility)

0.05 (Low)

Price

£9.46

Volume

18,711

Open

£9.40

Previous Close

£9.38

Daily Range

£9.40 - £9.54

52-Week Range

£5.84 - £10.10

IBT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About International Biotechnology Trust Plc

Industry

Capital Markets

Employees

0

Headquarters

London, WC2B 6ST, GB

IBT Financials

Key Financial Metrics (TTM)

Gross Margin

81%

Operating Margin

81%

Net Income Margin

82%

Return on Equity

26%

Return on Capital

24%

Return on Assets

22%

Earnings Yield

25.58%

Dividend Yield

3.39%

Payout Ratio

13.67%

Stock Overview

Market Cap

£298.54M

Shares Outstanding

31.83M

Volume

18.71K

Avg. Volume

48.62K

Financials (TTM)

Gross Profit

£14.38M

Operating Income

-£21.00K

EBITDA

-£21.00K

Operating Cash Flow

£28.63M

Capital Expenditure

-£28.63M

Free Cash Flow

£0.00

Cash & ST Invst.

£14.98M

Total Debt

£29.61M

International Biotechnology Trust Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

£87.88M

+171.1%

Gross Profit

£85.41M

+215.2%

Gross Margin

97.18%

N/A

Market Cap

£298.54M

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

£85.43M

+201.5%

EBITDA

£85.91M

+13714.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

-£26.78M

-45.2%

Accounts Receivable

£241.00K

-96.3%

Inventory

£0.00

N/A

Long Term Debt

£0.00

-100.0%

Short Term Debt

£29.75M

+7.5%

Return on Assets

22.24%

N/A

Return on Invested Capital

23.82%

N/A

Free Cash Flow

-£3.93M

-115.4%

Operating Cash Flow

-£3.93M

-115.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BSV.LBritish Smaller Companies VCT plc
£0.75+0.00%
ARR.LAurora Investment Trust plc
£2.41+0.63%
STS.LSTS Global Income & Growth Trust PLC
£2.23-1.65%
BIOG.LThe Biotech Growth Trust PLC
£12.40+0.68%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$16.73-0.01%
IBITiShares Bitcoin Trust
$37.00-0.03%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$37.19+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$86.56-0.01%

Questions About IBT

What is the current price of International Biotechnology Trust Plc?

International Biotechnology Trust Plc is trading at £9.46 per share.

What is the 52-week range for International Biotechnology Trust Plc?

Over the past 52 weeks, International Biotechnology Trust Plc has traded between £5.84 and £10.10.

How much debt does International Biotechnology Trust Plc have?

As of the most recent reporting period, International Biotechnology Trust Plc reported total debt of £29.61M.

How much cash does International Biotechnology Trust Plc have on hand?

International Biotechnology Trust Plc reported £14.98M in cash and cash equivalents in its most recent financial results.

What is International Biotechnology Trust Plc’s dividend yield?

International Biotechnology Trust Plc currently has a dividend yield of 3.39%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.